Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
JAMA Internal Medicine
|
July 5, 2022
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial
Lila Bouadma, Armand Mekontso-Dessap, Charles Burdet, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 20, 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients
Nadège Néant, Guillaume Lingas, Alexandre Gaymard, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2022
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, et al.
Cancers
|
July 26, 2020
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Nicolas Duployez, Jordane Demonchy, Céline Berthon, et al.
Fundamental & Clinical Pharmacology
|
April 20, 2021
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review
Nathalie Gault, Marina Esposito-Farèse, Matthieu Revest, et al.
Emerging Infectious Diseases
|
January 25, 2024
Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004-2023
Lucas Khellaf, Virginie Lemiale, Maxens Decavèle, et al.
Chest
|
January 19, 2021
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
Charles Tacquard, Alexandre Mansour, Alexandre Godon, et al.
Pharmacology Research & Perspectives
|
June 3, 2023
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial
Noémie Mercier, Drifa Belhadi, Aline DeChanet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 25, 2021
Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
Annabelle Dupont, Antoine Rauch, Senna Staessens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 29, 2024
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial
Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
JAMA Internal Medicine
|
July 5, 2022
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial
Lila Bouadma, Armand Mekontso-Dessap, Charles Burdet, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 20, 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients
Nadège Néant, Guillaume Lingas, Alexandre Gaymard, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2022
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
Guillaume Lingas, Nadège Néant, Alexandre Gaymard, et al.
Cancers
|
July 26, 2020
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Nicolas Duployez, Jordane Demonchy, Céline Berthon, et al.
Fundamental & Clinical Pharmacology
|
April 20, 2021
Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review
Nathalie Gault, Marina Esposito-Farèse, Matthieu Revest, et al.
Emerging Infectious Diseases
|
January 25, 2024
Critically Ill Patients with Visceral Nocardia Infection, France and Belgium, 2004-2023
Lucas Khellaf, Virginie Lemiale, Maxens Decavèle, et al.
Chest
|
January 19, 2021
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
Charles Tacquard, Alexandre Mansour, Alexandre Godon, et al.
Pharmacology Research & Perspectives
|
June 3, 2023
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial
Noémie Mercier, Drifa Belhadi, Aline DeChanet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 25, 2021
Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
Annabelle Dupont, Antoine Rauch, Senna Staessens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 29, 2024
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial
Vida Terzić, Joe Miantezila Basilua, Nicolas Billard, et al.
Page
of 9